Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Myelodysplastic Syndromes 9Lymphoma 7Leukemia, Lymphocytic, Chronic, B-Cell 6Neuroblastoma 5Lymphoma, Non-Hodgkin 5Leukemia 5Rhabdoid Tumor 3Neoplasms, Plasma Cell 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Wilms Tumor 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Medulloblastoma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Biphenotypic, Acute 2Graft vs Host Disease 2Ganglioneuroblastoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Sarcoma, Myeloid 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1

Interventions

Cytarabine 2venetoclax 1quizartinib 1devimistat 1Stem Cell Transplantation 1Mitoxantrone 1Hematopoietic Stem Cell Transplantation 1Daunorubicin 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Sarcoma, Myeloid × Stem Cell Transplantation × Clear all
NCT02484391 2024-09-19

CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma

Wake Forest University Health Sciences

Phase 1 Completed
48 enrolled 13 charts
Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡